Synthesis and anti-intracellular Copper overload evaluation of Nanoconjugated D-penicillamine –Dendrimer in Wilson’s model cells
Background and Objective: Wilson’s disease (WD) is caused by mutation to the cooer-transporting gene ATP7B. Chelation therapy is the main protochol of treatment for patients with Wilson’s disease. D-penicillamine is one of the well-known chelator agants which is used in WD treatment but it can not e...
Main Authors: | Fani N, Shafiee Ardestani M, Yaghmaei P, Assadi A, Barzegar Behrouz A |
---|---|
Format: | Article |
Language: | fas |
Published: |
Golestan University of Medical Sciences
2016-03-01
|
Series: | مجله دانشگاه علوم پزشکی گرگان |
Subjects: | |
Online Access: | http://goums.ac.ir/journal/browse.php?a_code=A-10-1-876&slc_lang=en&sid=1 |
Similar Items
-
Pompholyx-like eruptions induced by penicillamine in a patient with wilson's disease
by: Diana Elizabeth Devassy, et al.
Published: (2019-01-01) -
Penicillamine-induced virginal mammary hypertrophy
by: Daiwon Jun, et al.
Published: (2021-01-01) -
Hydrophilic Chlorin e6-Poly(amidoamine) Dendrimer Nanoconjugates for Enhanced Photodynamic Therapy
by: So-Ri Lee, et al.
Published: (2018-06-01) -
Management of children and adolescents with Wilson Disease and neurological worsening following D–Penicillamine therapy: A single centre experience
by: Madhan Kumar, et al.
Published: (2022-01-01) -
Nephrotic syndrome after treatment with d-penicillamine in a pediatric patient with Wilson’s disease
by: M. Farallo, et al.
Published: (2012-10-01)